We just received data on a new analyst forecast for $ADAP. Barclays gave a rating of 'Underweight' for $ADAP.
$ADAP Analyst Ratings
Wall Street analysts have issued reports on $ADAP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 05/14/2025
- Scotiabank issued a "Outperform" rating on 03/21/2025
To track analyst ratings and price targets for $ADAP, check out Quiver Quantitative's $ADAP forecast page.
$ADAP Insider Trading Activity
$ADAP insiders have traded $ADAP stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ADAP stock by insiders over the last 6 months:
- ADRIAN RAWCLIFFE (Chief Executive Officer) has made 0 purchases and 4 sales selling 90,170 shares for an estimated $52,412.
- ELLIOT NORRY (Chief Medical Officer) has made 0 purchases and 4 sales selling 27,779 shares for an estimated $16,163.
- WILLIAM C JR BERTRAND (Chief Operating Officer) has made 0 purchases and 4 sales selling 25,126 shares for an estimated $14,603.
- JOHN LUNGER (Chief Patient Supply Officer) has made 0 purchases and 4 sales selling 25,126 shares for an estimated $14,603.
- CINTIA PICCINA (Chief Commercial Officer) sold 12,991 shares for an estimated $7,467
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADAP Hedge Fund Activity
We have seen 24 institutional investors add shares of $ADAP stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MATRIX CAPITAL MANAGEMENT COMPANY, LP removed 37,681,515 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $20,299,032
- TWO SEAS CAPITAL LP added 14,835,146 shares (+inf%) to their portfolio in Q4 2024, for an estimated $7,991,693
- BAILLIE GIFFORD & CO removed 11,819,095 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,328,361
- LONG FOCUS CAPITAL MANAGEMENT, LLC added 7,194,503 shares (+54.1%) to their portfolio in Q4 2024, for an estimated $3,875,678
- PFM HEALTH SCIENCES, LP removed 5,128,818 shares (-51.3%) from their portfolio in Q4 2024, for an estimated $2,762,894
- BANK OF AMERICA CORP /DE/ removed 1,790,995 shares (-38.5%) from their portfolio in Q4 2024, for an estimated $964,809
- UBS GROUP AG added 870,996 shares (+614.5%) to their portfolio in Q1 2025, for an estimated $171,586
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
